HopeStage
Back to all studies
RecruitingNCT07539805

Sertraline with or without Lactobacillus crispatus for depression in adolescents

About this titleRead the official source — NCT07539805
Interventional studyAges 12–18China
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 12 years to 18 years. Other eligibility criteria apply.

Listed locations
Longgang and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 11, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
First Affiliated Hospital of Chongqing Medical University
Sponsor type
University
Study type
Drug
Intervention type
Combination product
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
China
Age range
From 12 Years to 18 Years
Official registry ID
NCT07539805
Official title
Show the full official title

Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression : A Multicenter Randomized Controlled Trial

Recruitment & locations

Currently recruiting

Longgang · Chongqing

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is First Affiliated Hospital of Chongqing Medical University, a university.

Who can participate?

This study is for people with depression. Listed age limits: 12 years to 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies